Parallax Volatility Advisers
ACOR

Parallax Volatility Advisers’s Acorda Therapeutics ACOR Stock Holding History

Parallax Volatility Advisers’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,421
Closed -$829K – 3269
2020
Q3 		$829K Buy
13,421
+11,861
+760% +$894K ﹤0.01% 2059
2020
Q2 		$138K Buy
1,560
+56
+4% +$5.92K ﹤0.01% 2315
2020
Q1 		$168K Buy
+1,504
New +$296K ﹤0.01% 2024
2018
Q1 		– Sell
-55
Closed -$142K – 4677
2017
Q4 		$142K Buy
+55
New +$156K ﹤0.01% 2554
2016
Q1 		– Sell
-2
Closed -$11K – 3958
2015
Q4 		$11K Buy
+2
New +$8.74K ﹤0.01% 2673

Other funds holding ACOR

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Parallax Volatility Advisers's ACOR Position: Q4 2020 in Review

Parallax Volatility Advisers sold out of Acorda Therapeutics (ACOR) in Q4 2020, closing a stake of 13,421 shares — an estimated $829K sold.

Parallax Volatility Advisers first reported a position in ACOR in Q4 2015 and held it in 5 quarters. The position peaked at $829K in Q3 2020. 47 funds tracked by Wall St. Rank hold ACOR as of Q4 2020.

  • Parallax Volatility Advisers reported no remaining Acorda Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 13,421 Acorda Therapeutics shares in Q4 2020, an estimated $829K.
  • Parallax Volatility Advisers first reported a position in Acorda Therapeutics in Q4 2015 and held it in 5 quarters.
  • Parallax Volatility Advisers's Acorda Therapeutics position peaked at $829K in Q3 2020.
  • 47 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2020.

Based on Parallax Volatility Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.